{"product_id":"carcinotest","title":"CarcinoTest™ – Circulating Tumor Cell Test","description":"\u003cp\u003e\u003cstrong\u003eCarcinoTest™\u003c\/strong\u003e is an advanced blood-based test designed to detect and evaluate \u003cstrong\u003eCirculating Tumor Cells\u003c\/strong\u003e, also known as \u003cstrong\u003eCTCs.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCTCs are cancer-related cells that may break away from a tumour and enter the bloodstream. Their presence may provide important information about cancer activity, possible spread, treatment response, and ongoing monitoring needs.\u003c\/p\u003e\n\u003cp\u003eUnlike conventional screening methods that rely mainly on imaging or tumour markers, CarcinoTest™ provides a deeper biological view by studying cancer-related cells circulating in the blood.\u003c\/p\u003e\n\u003cp\u003eThis makes CarcinoTest™ a valuable tool for doctor-led cancer monitoring, early investigation support, and personalised oncology planning.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT CARCINOTEST™ IS?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eCarcinoTest™ is a \u003cstrong\u003eCirculating Tumor Cell Test\u003c\/strong\u003e performed using a blood sample.\u003c\/p\u003e\n\u003cp\u003eCirculating Tumor Cells, or CTCs, are cells that may detach from a tumour and travel through the bloodstream. These cells are clinically important because they may be associated with cancer progression, recurrence risk, and metastatic potential.\u003c\/p\u003e\n\u003cp\u003eThis test may help doctors better understand whether cancer-related cells are present in circulation and whether further monitoring, investigation, or treatment-response review may be needed.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHY CIRCULATING TUMOR CELLS MATTER?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCancer cells may not always remain confined to the original tumour site.\u003c\/p\u003e\n\u003cp\u003eSome cells may enter the bloodstream and travel to other parts of the body. These circulating cells may act as early indicators of possible disease activity or microscopic spread.\u003c\/p\u003e\n\u003cp\u003eDetecting and monitoring CTCs may help provide useful insight into:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCancer-Cell Activity: \u003c\/strong\u003eHelps evaluate whether cancer-related cells are circulating in the bloodstream.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMicro-Metastatic Risk: \u003c\/strong\u003eMay support early understanding of possible microscopic spread risk.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTreatment Response: \u003c\/strong\u003eCan be used to compare changes before, during, or after cancer treatment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-Surgery Monitoring: \u003c\/strong\u003eMay help doctors monitor patients after surgery for additional biological insight.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePersonalised Oncology Planning: \u003c\/strong\u003eProvides additional information that may support doctor-led decision-making.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eHOW CARCINOTEST™ WORKS?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe process begins with a professional blood collection.\u003c\/p\u003e\n\u003cp\u003eThe blood sample is then analysed to identify and evaluate circulating tumour cells. The result may provide information about the presence, quantity, and biological characteristics of cancer-related cells in the bloodstream.\u003c\/p\u003e\n\u003cp\u003eThe general process includes:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eConsultation: \u003c\/strong\u003eThe patient’s medical history, cancer risk, symptoms, previous results, or current treatment status are reviewed.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood Collection: \u003c\/strong\u003eA blood sample is collected by trained healthcare personnel.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eLaboratory Analysis: \u003c\/strong\u003eThe sample is analysed to detect and evaluate circulating tumour cells.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eReport Generation:\u003c\/strong\u003e A report is prepared for doctor-led interpretation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Review:\u003c\/strong\u003e The result is reviewed together with the patient’s clinical condition, imaging, tumour markers, treatment history, and other relevant findings.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT MAKES CARCINOTEST™ DIFFERENT?\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood-Based Cancer Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCarcinoTest™ uses a blood sample to study circulating tumour cells, offering an additional layer of information beyond conventional tumour markers.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMinimally Invasive\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe test requires only a blood draw, without radiation exposure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Repeated Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eBecause it is blood-based, CarcinoTest™ may be repeated over time to monitor changes.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProvides Cellular-Level Insight\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eInstead of only looking at tumour size, CarcinoTest™ helps evaluate cancer-related cellular activity in circulation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Treatment Response Review\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eChanges in CTC levels or characteristics may help doctors assess how the patient is responding to treatment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Personalised Oncology Planning\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eThe result may help guide further investigation, monitoring frequency, or treatment-planning discussions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eKEY BENEFITS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDetects Circulating Tumor Cells\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eHelps identify cancer-related cells that may be present in the bloodstream.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Early Investigation\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay provide early biological insight when further cancer-related evaluation is needed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHelps Monitor Treatment Response\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eCan be used before, during, or after treatment to support response tracking.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSupports Post-Surgery Monitoring\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eMay help provide additional insight after tumour removal or cancer-related surgery.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGoes Beyond Routine Tumour Markers\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eProvides cellular-level information that may complement conventional blood tests and imaging.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUseful for Ongoing Cancer Management\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003eSupports doctor-led monitoring in patients undergoing chemotherapy, immunotherapy, targeted therapy, integrative oncology support, or follow-up care.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHO CARCINOTEST™ IS DESIGNED FOR?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCarcinoTest™ may be considered for individuals who require deeper cancer-related monitoring or investigation support.\u003c\/p\u003e\n\u003cp\u003eIt may be suitable for individuals who:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ehave a personal history of cancer\u003c\/li\u003e\n\u003cli\u003ehave a family history of cancer\u003c\/li\u003e\n\u003cli\u003ehave elevated or borderline tumour markers\u003c\/li\u003e\n\u003cli\u003eare undergoing cancer treatment\u003c\/li\u003e\n\u003cli\u003ewant to assess treatment response\u003c\/li\u003e\n\u003cli\u003ehave completed cancer surgery and require monitoring\u003c\/li\u003e\n\u003cli\u003ehave abnormal screening results requiring further investigation\u003c\/li\u003e\n\u003cli\u003ehave risk factors such as long-term smoking or chronic hepatitis B\/C\u003c\/li\u003e\n\u003cli\u003ehave positive stool occult blood test\u003c\/li\u003e\n\u003cli\u003ehave abnormal mammogram findings\u003c\/li\u003e\n\u003cli\u003ehave abnormal Pap smear \/ cervical screening findings\u003c\/li\u003e\n\u003cli\u003eare advised by a doctor to undergo further cancer-related evaluation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCarcinoTest™ should always be interpreted by qualified healthcare professionals.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWHEN CARCINOTEST™ MAY BE RECOMMENDED?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCarcinoTest™ may be considered:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ebefore starting a cancer treatment plan\u003c\/li\u003e\n\u003cli\u003eduring active cancer treatment\u003c\/li\u003e\n\u003cli\u003eafter chemotherapy, immunotherapy, targeted therapy, or surgery\u003c\/li\u003e\n\u003cli\u003eduring post-treatment follow-up\u003c\/li\u003e\n\u003cli\u003ewhen tumour markers are elevated or unclear\u003c\/li\u003e\n\u003cli\u003ewhen imaging results need additional biological context\u003c\/li\u003e\n\u003cli\u003ewhen there is concern about recurrence or microscopic spread\u003c\/li\u003e\n\u003cli\u003ewhen doctors require deeper cancer-cell activity information\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eWHAT THE RESULT MAY SHOW?\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCarcinoTest™ may provide information related to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003epresence of circulating tumour cells\u003c\/li\u003e\n\u003cli\u003eCTC count or level\u003c\/li\u003e\n\u003cli\u003ecancer-cell activity in circulation\u003c\/li\u003e\n\u003cli\u003epossible metastatic potential\u003c\/li\u003e\n\u003cli\u003etreatment-response trend\u003c\/li\u003e\n\u003cli\u003epost-surgery monitoring insight\u003c\/li\u003e\n\u003cli\u003eneed for further investigation or closer follow-up\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eA concerning result does not automatically confirm cancer progression. It must be reviewed together with imaging, tumour markers, symptoms, medical history, and doctor assessment.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIMPORTANT NOTICE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCarcinoTest™ is a professional cancer monitoring and investigation-support test. It is not intended to independently diagnose cancer, treat cancer, cure cancer, or prevent cancer.\u003c\/p\u003e\n\u003cp\u003eResults must be interpreted by qualified medical professionals and reviewed together with the patient’s symptoms, medical history, imaging, tumour markers, laboratory findings, treatment status, and overall clinical condition.\u003c\/p\u003e\n\u003cp\u003eFurther medical investigation may be required depending on the result and clinical context.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"CytoLife","offers":[{"title":"Default Title","offer_id":41829122932772,"sku":"","price":17890.0,"currency_code":"MYR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/8665\/8084\/files\/Cell_Tissue_UKM_CarcinoTest.jpg?v=1780480862","url":"https:\/\/shop.cytolifeasia.com\/zh\/products\/carcinotest","provider":"CytoLife","version":"1.0","type":"link"}